Quality assurance of clinical data: invited remarks. Remarks on quality enhancement in SENIC.
作者信息
Lachenbruch P A
出版信息
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):724.
PMID:373963
Abstract
摘要
相似文献
1
Quality assurance of clinical data: invited remarks. Remarks on quality enhancement in SENIC.
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):724.
2
Quality assurance of clinical data: invited remarks.临床数据的质量保证：特邀致辞。
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):725.
3
Quality assurance of clinical data: diagnostic standardization.临床数据的质量保证：诊断标准化。
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):703-11.
4
Special issue: The SENIC Project.
Am J Epidemiol. 1980 May;111(5):465-653.
5
When and how to stop a clinical trial: invited remarks.何时以及如何终止一项临床试验：特邀评论
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):647-8.
6
When and how to stop a clinical trial: invited remarks.何时以及如何终止一项临床试验：特邀评论
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):649-50.
7
General comments on the study on the efficacy of nosocomial infection control (SENIC Project).关于医院感染控制效果研究（SENIC项目）的总体评论。
Am J Epidemiol. 1980 May;111(5):465-9. doi: 10.1093/oxfordjournals.aje.a112926.
8
Ethical considerations in clinical trials: invited remarks.临床试验中的伦理考量：特邀演讲
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):742-6.
9
When and how to stop a clinical trial: invited remarks.
Clin Pharmacol Ther. 1979 May;25(5 Pt 2):651-4.
10
[Research design, quality control and evaluation in epidemiological evaluation study].[流行病学评估研究中的研究设计、质量控制与评价]
Zhonghua Liu Xing Bing Xue Za Zhi. 1996 Oct;17(5):281-4.
Zotero 插件